Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Diagnosis and Therapeutic Management of Gastrointestinal Cancers"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (15 May 2023) | Viewed by 8686
Special Issue Editors
Interests: internal medicine; gastroenterology; hepatology; haematology
Interests: abdominal surgery; gastroenterology; rectal cancer
Special Issue Information
Gastrointestinal cancers are showing increasing incidence and mortality rates worldwide and are responsible for 4.8 million new cancer cases and 3.4 million cancer related deaths per year (WHO 2018).
Most cases belong to the “big five”, affecting the esophagus, stomach, liver, colon and rectum as well the pancreato-biliary system.
Although some of the mentioned entities still are associated with a poor prognosis, new therapeutic modalities have led to an improvement in the outcome of affected patients.
In addition to advances in combinations of conventional chemotherapy with targeted treatment options and upcoming immunotherapy, novel strategies in tumor treatment, such as neoadjuvant protocols and improved timing (e.g., “liver first”) in the use of these multimodal approaches, have yielded remarkable benefits for the patients.
Translational and clinical research introduction of targeted immune and/or chemotherapy regimens as well as advancements in new surgical technology (minimal invasive surgery, robotic surgery) have led to a significant reduction of morbidity and shown increasingly promising results in the recent past.
Despite these observations of new advancements, challenges still remain, including regarding issues of preventive measures (e.g., screening for chronic hepatitis, preventive endoscopies, etc.) as well as healthcare and/or reimbursement questions.
This upcoming issue of Cancers will cover some of the topics related to the diagnosis and therapeutic management of gastrointestinal cancers by presenting reviews and/or meta-analyses as well as recent results from original research.
Prof. Dr. Christian Sebesta
Prof. Dr. Harald Rainer Rosen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- esophagus tumor
- targeted immune and/or chemotherapy
- surgical technology
- multimodal approach
- therapeutic management